|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 412 1st Street, SE |
Address2 | Suite 3 |
City | Washington |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400660986-24
|
||||||||
|
6. House ID# 414350000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: G. David Mason |
Date | 7/23/2021 2:26:54 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Legislation and policies related to:
Physician/nurse practitioner reimbursement
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity
Extension of Medicare and Medicaid waivers beyond the COVID-19 public health emergency
Medicare and Medicaid restrictions related to telehealth services
Medicaid maintenance of effort requirements
Medicaid eligibility expansion and state options
Medicaid waiver application procedures
H.R. 265, Insular Area Medicaid Parity Act
H.R. 1025, Kids Access to Primary Care Act of 2021
H.R. 1353/S. 439, Coronavirus Medicaid Response Act
H.R. 1577, To amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes
H.R. 1956, Increasing Access to Quality Cardiac Rehabilitation Care Act of 2021
H.R. 3447, Permanency for Audio-Only Telehealth Act
S. 245, States Achieve Medicaid Expansion (SAME) Act of 2021
S. 646/H.R. 1738, Stabilize Medicaid and CHIP Coverage Act
S. 800, Promoting Access to Diabetic Shoes Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Legislation and policies relating to:
Adoption of recommendations of the National Academy of Medicine report, The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Reauthorization of the Childrens Health Insurance Program
Reauthorization of the Child Nutrition Act
Section 2706 of the ACA regarding provider non-discrimination
Policies affecting nurse practitioner education and workforce
Definition, evaluation and enforcement of essential health benefits and provider network adequacy
Health information technology and electronic health records
Mental health services and violence prevention
H. Res. 390/S. Res. 208, Supporting the goals and ideals of National Nurses Week, to be observed from May 6 through May 12, 2021
H.R. 66, Comprehensive Access to Robust Insurance Now Guaranteed for Kids (CARING for Kids) Act
H.R. 379/S. 104, Improving Social Determinants of Health Act of 2021
H.R. 482, Newborn Screening Saves Lives Reauthorization Act of 2021
H.R. 485, Stronger Child Abuse Prevention and Treatment Act
H.R. 959/S. 346, Black Maternal Health Momnibus Act of 2021
H.R. 1065/S. 1486, Pregnant Workers Fairness Act
H.R. 1314, Stop Tip-overs of Unstable, Risky Dressers on Youth (STURDY) Act
H.R. 1319, American Rescue Plan Act of 2021
H.R. 1390, Childrens Health Insurance Program Pandemic Enhancement and Relief (CHIPPER) Act
H.R. 1791, Childrens Health Insurance Program Permanency (CHIPP) Act
H.R. 2347, Strengthening the Vaccines for Children Program Act of 2021
H.R. 2503, Social Determinants Accelerator Act of 2021
H.R. 3182, Safe Sleep for Babies Act of 2021
S. 32/H.R. 460, Health Force, Resilience Force, and Jobs to Fight COVID-19 Act of 2021
S. 104/H.R. 379, Improving Social Determinants of Health Act of 2021
S. 248/H.R. 804, Family and Medical Insurance Leave (FAMILY) Act
S. 499/H.R. 369, Improving Health Insurance Affordability Act of 2021
S. 509, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021
S. 610/H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act
S. 674, Public Health Infrastructure Saves Lives Act
S. 987, Comprehensive Addiction and Recovery Act (CARA) 3.0
S. 1259, Safe Cribs Act
S. 1301/H.R. 2094, Promoting Physical Activity for Americans Act
S. 1658/H.R. 3110, Providing Urgent Maternal Protections for Nursing Mothers Act
S. 1675, Maternal Health Quality Improvement Act
S. 1927, the Child Abuse Prevention and Treatment Act (CAPTA) Reauthorization Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Legislation and policies relating to:
Authorization and appropriations of Title VIII funding for nurse education and nurse workforce development programs and for the National Institute of Nursing Research in fiscal years 2021 and 2022
H. Res. 467, Providing for budget allocations for the Committee on Appropriations
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Legislation and policies related to:
Pediatric and childrens health research
National Institute of Nursing Research
H.R. 1716, COVID-19 Mental Health Research Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Legislation and policies related to:
Immigration, visa status, and deportation of children and families with children, including the Deferred Action for Childhood Arrivals program
H.R. 6, American Dream and Promise Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Legislation and policies related to:
Accreditation and curriculum of advance practice nursing education programs
Policies and requirements related to scholarship and loan repayment programs for advanced practice registered nurses
S. 54, Strengthening Americas Health Care Readiness Act
S. 246/H.R. 851, Future Advancement of Academic Nursing (FAAN) Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Legislation and policies related to:
Environmental protections affecting the health and safety of children, families, and health care providers
H.R. 1512, Climate Leadership and Environmental Action for our Nations Future (CLEAN Future) Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Legislation and policies related to:
Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices
Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices
H.R. 2125, Quit Because of COVID-19 Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Legislation and policies related to:
Revision and implementation of Department of Veterans Affairs regulation RIN 2900-AP44, Advanced Practice Registered Nurses
S. 1220/H.R. 22568, United States Cadet Nurse Corps Service Recognition Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Legislation and policies related to:
Prescription and administration of buprenorphine and other medication assisted treatment by nurses and advanced practice registered nurses for the treatment of opioid or substance use disorders
H.R. 1384, Mainstreaming Addiction Treatment Act of 2021
H.R. 2067, Medication Access and Training Expansion (MATE) Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Substance Abuse & Mental Health Services Administration (SAMHSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Legislation and policies related to:
Workplace safety and violence prevention for nurse, advanced practice registered nurses, and other health care professionals
H.R. 1195, Workplace Violence Prevention for Health Care and Social Service Workers Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Legislation and policies relating to:
Physical activity and recreation
Provisions of the Investing in a New Vision for the Environment and Surface Transportation (INVEST) in America Act (H.R. 3684) related to safe, accessible transportation alternatives
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dave |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |